American Journal of Physical Medicine & Rehabilitation · 2001 · 29 citations · 8 references
MedicinePharmacotherapyRehabilitation MedicineRespiratory PharmacotherapySleep MedicineSleep NeurologyCerebral PalsyPositive Airway Pressure TherapySleep Apnea CareSleep-disordered BreathingSleep-related Breathing DisordersSpasticity ManagementGross Motor Function AssessmentModified Ashworth ScaleMuscle SpasticitySpastic Cerebral Palsy
Intrathecal baclofen (ITB) can reduce spasticity in adults and children with cerebral palsy. Benefits of ITB therapy include improved Ashworth scores, activities of daily living, and mobility. The impact of ITB therapy on sleep apnea in patients with cerebral palsy has not been reported. This case report describes a 29-yr-old female with mixed spastic athetoid quadriparetic cerebral palsy with dystonia, gross motor function IV, who had sleep apnea, requiring nightly continuous positive airway pressure. She received ITB with the goal to improve her wheelchair positioning and decrease her excessive movements. After the initiation of the ITB, reduction of her spasticity and dystonia was noted, as well as improvement of her sleep apnea. This case suggests that ITB therapy may improve respiratory function through reduction of respiratory muscle spasticity.
8
Intrathecal Baclofen for Severe Spinal Spasticity
Richard D. Penn, Suzanne M. Savoy, Daniel M. Corcos et al. · New England Journal of Medicine · 1989 · 750 citations
Medicine, Neurology, Neurosurgery +17
Continuous Intrathecal Baclofen Infusion for Spasticity of Cerebral Origin
A. Leland Albright · JAMA · 1993 · 300 citations
Medicine, Neurology, Pharmacotherapy +14
Topical Review: Baclofen in the Treatment of Cerebral Palsy
A. Leland Albright · Journal of Child Neurology · 1996 · 201 citations
Medicine, Neurology, Pharmacotherapy +15